Examining the changes in the illicit drug market in a state.
Official title: Applying a multiple methods approach to examine spatial and temporal variability in a state's illicit drug market
Funded at Yale University · NIH-11104204 · Data updated 2026-11-12
This study is looking into the illegal drug market, especially how fentanyl and other synthetic drugs are affecting communities, and it’s for anyone interested in finding better ways to tackle the opioid crisis by understanding what drugs are out there and how they’re being used.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | June 1, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $688,271 |
| NIH project number | 1R01DA062622-01 |
| Project ID | NIH-11104204 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals who use drugs, particularly in urban areas experiencing high rates of overdose and drug-related issues.
✕Less likely to help
Patients who do not use illicit drugs or are not affected by the opioid crisis may not receive any benefit from this research.
What this research studies
This research investigates the current dynamics of the illicit drug market, particularly focusing on the impact of fentanyl and other synthetic drugs. It aims to gather comprehensive data by testing drugs used by individuals and analyzing wastewater in communities. By understanding the prevalence and types of substances circulating, the research seeks to inform better responses to the opioid crisis, especially in urban areas with high overdose rates. The approach includes engaging with people who use drugs to collect samples and data effectively.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for addressing the opioid crisis and reducing overdose deaths in affected communities.
How similar studies have gone: Previous research has shown success in using similar methods to analyze drug markets and inform public health responses, indicating a promising approach.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Heimer, Robert — Yale University
- Study coordinator: Heimer, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.